09/11/2015 - 12:16pm

NY AG renews efforts against dietary supplement industry with 13 new cease-and-desist letters. 

09/10/2015 - 11:18am

There is concern that industry consolidation in the healthcare sector may hamper patient access and the ability of community pharmacists to provide care. 

09/08/2015 - 12:33pm

The Centers for Disease Control and Prevention has launced its new program, “Prescription Drug Overdose: Prevention for States,” which aims to invest in 16 states currently battling an epidemic of prescription drug overdoses. 

09/04/2015 - 12:14pm

The Council for Responsible Nutrition this week came out in support of the Food and Drug Administration taking action against marketing bulk pure powdered caffeine to consumers and its issuance of warning letters to five powdered caffeine distributors.

09/04/2015 - 11:53am

The Food and Drug Administration this week approved expanded labeling for Janssen Biotech’s rheumatoid arthritis treatment Simponi Aria (golimumab for infusion).

09/04/2015 - 11:23am

AstraZeneca on Thursday announced that the Food and Drug Administration approved Brilinta (ticagrelor) tablets at a 60 mg dose for patients with a history of heart attack beyond the first year.

09/03/2015 - 10:01am

California state Sen. Jeff Stone, a former independent pharmacist himself, had one message for independent pharmacists during the McKesson ideaShare 2015 Public Policy session in San Diego — don’t just vote, get involved.

08/31/2015 - 3:31pm

The guidance was outlined in a blog post by Janet Woodcock, director of the FDA’s center for drug evaluation and research, and Karen Midthum, director of the FDA’s center for biologics evaluation and research.

08/28/2015 - 12:01pm

The Food and Drug Administration has a new diabetes treatment developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Co.